- Home
- INMB vs DXR Comparison
INMB vs DXR Comparison
Compare INMB & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- DXR
- Stock Information
- Founded
- INMB 2015
- DXR 1970
- Country
- INMB United States
- DXR United States
- Employees
- INMB N/A
- DXR N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- DXR Medical/Dental Instruments
- Sector
- INMB Health Care
- DXR Health Care
- Exchange
- INMB Nasdaq
- DXR Nasdaq
- Market Cap
- INMB 55.0M
- DXR 46.9M
- IPO Year
- INMB 2019
- DXR N/A
- Fundamental
- Price
- INMB $1.98
- DXR $13.50
- Analyst Decision
- INMB Buy
- DXR Strong Buy
- Analyst Count
- INMB 4
- DXR 1
- Target Price
- INMB $9.53
- DXR $25.00
- AVG Volume (30 Days)
- INMB 564.4K
- DXR 5.1K
- Earning Date
- INMB 10-30-2025
- DXR 01-01-0001
- Dividend Yield
- INMB N/A
- DXR N/A
- EPS Growth
- INMB N/A
- DXR 3.46
- EPS
- INMB N/A
- DXR 0.36
- Revenue
- INMB $50,000.00
- DXR $66,306.00
- Revenue This Year
- INMB $142.83
- DXR N/A
- Revenue Next Year
- INMB $14,780.90
- DXR N/A
- P/E Ratio
- INMB N/A
- DXR $38.30
- Revenue Growth
- INMB N/A
- DXR N/A
- 52 Week Low
- INMB $1.71
- DXR $6.55
- 52 Week High
- INMB $11.64
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- INMB 41.99
- DXR 66.65
- Support Level
- INMB $1.92
- DXR $13.39
- Resistance Level
- INMB $2.16
- DXR $14.00
- Average True Range (ATR)
- INMB 0.11
- DXR 0.50
- MACD
- INMB 0.03
- DXR 0.13
- Stochastic Oscillator
- INMB 42.86
- DXR 80.93
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.